Sacramento Signed Simmons to Cure Fragility. The Achilles Tear Proves the Disease Followed the Roster.

There is a version of this offseason that makes sense on paper. The Kings released DeMar DeRozan, pivoted to Zach LaVine as their offensive cornerstone, brought in Russell Westbrook to push the pace, and added Ben Simmons — a three-time All-Star on a one-year, $3.5 million deal — as a low-risk reclamation bet. Defensive versatility, playmaking, a former No. 1 overall pick trying to rediscover himself. The logic was sound. The problem is that Sacramento's durability crisis is not a personnel problem. It is a franchise condition. And no offseason architecture survives contact with it.

Simmons tore his right Achilles in practice on October 18. Seven days earlier, Maxime Raynaud — the second-year center who had become one of the few genuinely productive big men on this roster — went down with a patellar subluxation in his right knee during a preseason game. The season had not yet begun. The reset was already broken. What the front office tried to build as a bridge to competitiveness had collapsed before a single regular-season possession was played.

I wrote in September that this franchise had restructured itself around LaVine's ceiling and that everything depended on him staying healthy. That concern was warranted, and LaVine has actually held up — 18.9 points per game on 48.4% shooting over 43 games is exactly the production Sacramento needed from him. The problem is that a cornerstone requires a building around it. Raynaud is out. Simmons is done for the year. What remains is a collection of players carrying roles they were never meant to carry: Dennis Schroder and Precious Achiuwa as de facto starters, Malik Monk as a primary offensive option, Dylan Cardwell as the starting center on a team that needed far more from that position. Devin Carter's minutes have jumped sharply in recent weeks — a symptom of the same illness that felled the veterans above him.

The historical precedent here is unambiguous and unsparing. Teams that absorb multiple major injuries before the season begins — particularly to players signed specifically to provide complementary structure — do not recover. The 2013-14 Brooklyn Nets lost their entire core to age and injury and finished below .500 despite one of the most expensive rosters ever assembled. The 2018-19 Golden State Warriors watched their depth evaporate in the Finals and never fully recovered the dynasty's momentum. The through-line is not talent; it is the inability of any roster to function when its connective tissue is gone. Sacramento's connective tissue is now on the operating table.

The cruelest part of this is what the Simmons signing actually represented. He was not brought in to be a star. He was brought in because the Kings knew their margin for error was thin — LaVine and Westbrook are scorers, not defenders, and Simmons in even partial form offered the kind of switchable, passing-forward presence that could paper over some of the roster's structural gaps. He told the media he knew exactly what he could bring to this team. He was right about the fit. He never got the chance to prove it. An Achilles tear in practice, before the season began in earnest, is not a basketball failure. It is a reminder that some rosters carry a kind of gravitational pull toward catastrophe that no front office move can fully escape.

Sacramento is 22-62, eliminated, and losing by nearly nine points per game over their last ten. The Kings can stay close — they are 10-12 in games decided by five or fewer — but they cannot close, and at this point they cannot even field the team they designed. The declaration I will stand on is this: the 2026-27 Kings will be remembered not as a team that failed to compete, but as a team that never had the chance to find out whether it could. The durability crisis that Sacramento tried to cure with this offseason reset did not respond to the treatment. It consumed the medicine instead.